Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Helius Medical Technologies Inc (HSM.TO)

Helius Medical Technologies Inc (HSM.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 45,397
  • Shares Outstanding, K 2,317
  • Annual Sales, $ 661 K
  • Annual Income, $ -14,130 K
  • 60-Month Beta 1.06
  • Price/Sales 42.05
  • Price/Cash Flow N/A
  • Price/Book 3.03
Trade HSM.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -8.07
  • Most Recent Earnings -1.65 on 03/31/21
  • Next Earnings Date 08/12/21
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Medical Devices

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -1.85
  • Number of Estimates 1
  • High Estimate -1.85
  • Low Estimate -1.85
  • Prior Year -3.85
  • Growth Rate Est. (year over year) +51.95%

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.12 unch
on 07/26/21
21.14 -9.56%
on 06/29/21
-2.05 (-9.68%)
since 06/25/21
3-Month
15.75 +21.40%
on 05/25/21
21.50 -11.07%
on 04/27/21
-1.88 (-8.95%)
since 04/26/21
52-Week
14.26 +34.08%
on 01/04/21
40.00 -52.20%
on 01/05/21
-6.08 (-24.13%)
since 07/24/20

Most Recent Stories

More News
Helius Medical Technologies, Inc. to Present at Two Upcoming Investor Conferences in July

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that management will participate in the following...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 15.28 (-2.98%)
HSM.TO : 19.12 (-2.40%)
Helius Medical Technologies, Inc. Appoints Antonella Favit-Van Pelt, M.D., Ph.D. as Chief Medical Officer

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced the appointment of Antonella Favit-Van Pelt,...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 15.28 (-2.98%)
HSM.TO : 19.12 (-2.40%)
JNJ : 171.87 (+0.05%)
TEVA : 8.94 (+1.48%)
BMY : 67.69 (-0.95%)
Helius Medical Technologies, Inc. to Participate in the Annual World Congress of the Society for Brain Mapping and Therapeutics

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced it will participate in the Annual World Congress...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 15.28 (-2.98%)
HSM.TO : 19.12 (-2.40%)
Helius Medical Technologies, Inc. to Release Second Quarter of Fiscal Year 2021 Financial Results on August 12, 2021

Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that second quarter of fiscal year 2021 financial...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 15.28 (-2.98%)
HSM.TO : 19.12 (-2.40%)
Helius Medical Technologies, Inc. Expands Executive Leadership Team with the Appointment of Dane C. Andreeff as President and Chief Executive Officer and Jeffrey S. Mathiesen as Chief Financial Officer

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that Dane C. Andreeff and Jeffrey S. Mathiesen...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 15.28 (-2.98%)
HSM.TO : 19.12 (-2.40%)
Helius Medical Technologies, Inc. to Participate in Noble Capital Markets' Virtual Road Show Series

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM), ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced its participation in Noble Capital Markets'...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 15.28 (-2.98%)
HSM.TO : 19.12 (-2.40%)
Helius Medical Technologies, Inc. Appoints Frederick Fantazzia as Vice President of Sales & Marketing, North America

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced the appointment of Frederick Fantazzia to the...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 15.28 (-2.98%)
HSM.TO : 19.12 (-2.40%)
LIVN : 84.07 (+1.35%)
Helius Medical Technologies, Inc. Reports First Quarter 2021 Financial Results

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today reported financial results for the quarter ended March...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 15.28 (-2.98%)
HSM.TO : 19.12 (-2.40%)
Keynotes, Educational Panels and 66 Companies to Present at the Planet MicroCap Showcase: VIRTUAL on April 20-22, 2021

The Planet MicroCap Showcase will take place on April 20-22, 2021, where 66 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global investor audience....

BNXA.VN : 3.420 (+12.87%)
FARM.VN : 0.690 (unch)
EQ.VN : 1.420 (-1.39%)
GEM.VN : 0.130 (unch)
HIVE.VN : 3.200 (+16.79%)
SCAN.VN : 0.610 (unch)
NSCI.VN : 1.370 (unch)
QIS.VN : 1.100 (+4.76%)
TBRD.VN : 4.180 (+1.21%)
VMC.VN : 6.910 (-2.26%)
VYGR.CN : 18.500 (+8.89%)
ADGS : 0.1750 (-4.89%)
ARHH : 1.7200 (-3.64%)
BNXAF : 2.7355 (+13.04%)
BAMM.CN : 0.445 (unch)
BMMJ : 0.3635 (+0.97%)
CRGE : 3.1300 (-2.19%)
CTHR : 2.63 (-0.38%)
CTS.TO : 10.17 (-2.21%)
CTSDF : 8.0938 (-2.13%)
DN.TO : 0.4100 (-2.38%)
VRNDF : 0.4125 (+3.80%)
SOLO : 3.50 (unch)
ENVB : 1.9100 (-0.52%)
FANS.CN : 0.740 (-3.90%)
FUNFF : 0.5921 (-1.56%)
BUSXF : 7.5000 (-6.25%)
HAVN.CN : 0.385 (-4.94%)
HAVLF : 0.3030 (-4.27%)
HSM.TO : 19.12 (-2.40%)
HSDT : 15.28 (-2.98%)
HVBTF : 2.8595 (+4.17%)
ISDR : 27.39 (-2.14%)
JROOF : 0.7000 (+3.47%)
LLKKF : 0.3130 (+1.23%)
LEAF.TO : 0.2950 (+9.26%)
LDDFF : 0.4800 (-2.08%)
MMMB : 2.56 (-0.39%)
MCLDF : 1.7426 (+7.51%)
MEEC : 0.9700 (-2.49%)
MRV.TO : 1.25 (-5.30%)
MRVFF : 1.0133 (-3.40%)
MITI : 0.1948 (-0.10%)
NSCIF : 1.0999 (-0.91%)
NM.CN : 1.010 (-2.88%)
NVMDF : 0.8215 (+0.43%)
PERK.CN : 0.090 (+5.88%)
PKLBF : 0.0734 (+4.71%)
PYR.TO : 4.63 (-3.54%)
PYR : 3.72 (-2.62%)
LUKEF : 0.3291 (-1.76%)
REKR : 7.81 (+3.86%)
RIII : 0.0504 (-0.59%)
SFET : 1.1800 (unch)
SKYE : 0.1500 (+3.45%)
SIRC : 0.4050 (-3.46%)
SZLS.TO : 0.4500 (+2.27%)
TGCB : 0.6000 (-14.29%)
TEKCF : 0.2390 (-4.40%)
TMGEF : 0.1420 (unch)
THBRF : 3.3517 (+1.88%)
TOMDF : 0.0285 (-6.25%)
MEDS : 5.26 (-4.01%)
GROW : 5.78 (+3.21%)
UCLE : 0.5300 (+0.04%)
VSQTF : 0.3588 (-6.05%)
VMAR : 7.18 (-3.88%)
VNRX : 2.98 (-2.61%)
VYGVF : 14.7800 (+9.64%)
WELL.TO : 7.43 (+0.13%)
WTEQ.CN : 0.095 (-5.00%)
WWR : 3.96 (-1.98%)
Helius Medical Technologies, Inc. to Present at the Planet MicroCap Showcase on April 21st

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that management will participate in the Planet...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 15.28 (-2.98%)
HSM.TO : 19.12 (-2.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 19.12
2nd Resistance Point 19.12
1st Resistance Point 19.12
Last Price 19.12
1st Support Level 19.12
2nd Support Level 19.12
3rd Support Level 19.12

See More

52-Week High 40.00
Fibonacci 61.8% 30.17
Fibonacci 50% 27.13
Fibonacci 38.2% 24.09
Last Price 19.12
52-Week Low 14.26

See More

Business Summary

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license or acquire unique and non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's first product, known as the Portable Neuromodulation...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar